Loading clinical trials...

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00110513

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

Patients with hereditary antithrombin deficiency are at increased risk of venous thrombosis and pulmonary embolism, particularly during certain high risk procedures. The trial focused on patients with...

Lead sponsor: rEVO Biologics•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

TERMINATEDPhase 2

Antithrombin III in Infectious Disease Caused by COVID-19

NCT04899232 · Antithrombin III Deficiency, Covid19

COMPLETED

Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO

NCT04879550 · Antithrombin III Deficiency, Extracorporeal Membrane Oxygenation Complication

WITHDRAWNPhase 4

Atenativ Effect on Uterine Blood Flow and Preeclampsia

NCT02278575 · Antithrombin III Deficiency

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 17, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment18

Start dateApr 2005

Last updatedAug 17, 2012

Condition

Antithrombin III Deficiency

Locations shown

New Haven, Connecticut

St Louis, Missouri

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 17, 2012Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions